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Abstract—Digital bio-detection allowing for counting 
individual biomarker molecules and biological nanoparticles 
provides resolution and sensitivity beyond the reach of ensemble 
measurements. Single molecule and nanoparticle detection is 
considered the new frontier in biomarker analysis. Here we 
review several promising optical techniques for single molecule 
detection and describe single-particle interferometric reflectance 
imaging sensor (SP-IRIS). We present the challenges associated 
with reliable optical detection and discrimination of single 
biological nanoparticles and evolution of SP-IRIS from a 
laboratory instrument to a robust technology with potential 
impact in clinical diagnostic applications. Although 
interferometric optical imaging has been well established for 
nanoparticle characterization, the translation to a diagnostic 
context requires a significant paradigm shift in instrumentation 
requirements, image acquisition and processing. Here we 
describe a robust image processing method for discrimination 
and accurate counting of nanoparticles to overcome the 
variations in the optical signatures of nanoparticles due to 
ambiguities of focal plane and the specific axial location of the 
nanoparticles in wide-field imaging using a common path 
interferometric enhancement. 
 
Index Terms— Optical biosensing, digital detection, 
nanoparticle imaging, interferometry, single particle detection 
I. INTRODUCTION 
 
he development of optical tools for detection and 
characterization of nanoparticles will impact a broad range of 
disciplines in biological research from nanomedicine to 
nanotoxicology [1]. Single-molecule counting or digital 
detection provides resolution and sensitivity beyond the reach 
of ensemble measurements.  The impressive capabilities of 
 
Manuscript received June 24, 2016. This work was supported in part by the 
National Institutes of Health (R21 GM074872-01A1, R21EB015900, 
R01AI1096159), the Army Research Laboratory (W911NF-06-2-0040), 
National Science Foundation (OISE-0601631, EEC-0812056, AIR-1127833), 
MITRE Corporation, Center for Integration of Medicine and Innovative 
Technology (CIMIT). O. Avci acknowledges support from BU-BAU 
Fellowship.  
Jacob Trueb is with the Department of Mechanical Engineering Boston 
University, 8 St. Mary’s Street, Boston, MA 02215. 
M. Selim Ünlü and Oguzhan Avci are with the Department of Electrical 
and Computer Engineering, Boston University, 8 St. Mary’s Street, Boston, 
MA 02215, USA (617-353-5067 e-mail: selim@bu.edu, oguzhan@bu.edu) 
John H. Connor is with the Microbiology Department, Boston University 
School of Medicine, Boston, MA 02118, USA 
 
‡Jacob Trueb and Oguzhan Avci contributed equally to this work. 
digital detection schemes have led to desire for the translation 
of these techniques into clinically useful applications [2]. In 
order to realize the diagnostics potential, future research 
efforts should focus on the development of practical systems 
with infrastructural requirements better aligned with the 
functional realities of a clinical environment.   
In vitro detection of nucleic acid and protein biomarkers are 
an indispensable component of modern clinical practice.  The 
sub-wavelength size scale of these biomolecules makes direct 
detection through traditional methods extremely challenging.  
As such, modern gold standards rely upon amplification 
methods to generate a detectable signal that scales with 
analyte concentration.  Recent advancements in PCR 
(polymerase chain reaction) and ELISA (Enzyme Linked 
Immunosorbent Assays) have enabled the routine detection of 
trace levels of nucleic acid and protein biomarkers.  While 
these gold standard techniques achieve impressive results, 
they rely heavily upon a complicated sequence of sample 
preparation and amplification processes that limits their 
effectiveness outside of well-equipped laboratory 
environments.  On the other hand, rapid and point-of-care 
(POC) testing is commonly performed with lateral-flow style 
Rapid Diagnostic Tests (RDTs), which achieve qualitative 
biomarker detection in a robust and easy to use format. 
Digital detection techniques offer the potential to fill the 
diagnostic gap between ultrasensitive laboratory gold standard 
assays and qualitative POC tests.  Recent developments in 
optical digital detection schemes have demonstrated assay 
sensitivity on par with laboratory gold standards while 
maintaining compatibility with the direct use of minimally 
processed samples (serum, plasma, and whole blood), 
resulting in sensitive assays with reduced infrastructural 
requirements and sample-to-answer time. 
While digital detection of biomarkers is heralded as the new 
frontier in biomarker analysis [3], single nanoparticle 
detection remains challenging and often sophisticated 
instrumentation is required, limiting the applications to 
research laboratories. Many of the preliminary studies on 
digital detection platform are done in controlled, research 
contexts with limited scope and scale.  In these conditions, it is 
possible to maintain levels of quality control and calibration 
that may not be possible in a clinical environment.  In this 
paper, we review a number of optical techniques for the direct 
detection of biomarkers, with an emphasis on assays 
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demonstrating high throughput, wide sample compatibility, 
and robust operation.  Specifically, we focus on imaging 
techniques using a solid-phase substrate with micro-arrayed 
capture probe functionalization.  To overcome the obstacles 
associated with this modality, it is important to understand the 
specific requirements of biomarker detection via imaging.  
First of all, the detection methodology must discriminate 
target nanoparticles specifically bound to molecular probes 
from those in bulk solution.  Because surface immobilized 
capture probes have inherent non-uniformity, assay robustness 
is predicated on the ability to identify specific binding events 
in the presence of large amounts of background signal.  
Additionally, while digital detection methods are frequently 
compatible with complex media(serum, whole blood, urine, 
saliva), nonspecific binding from these solutions further 
increases the challenges of specific analyte discrimination.  
 We have demonstrated an optical imaging technique, 
known as the single-particle interferometric reflectance 
imaging sensor (SP-IRIS) that can detect single nanoscale 
particles [4]. The technology is based on the interference of 
light scattered by specifically bound particles with reflections 
from an optically transparent thin film. Optical scattering from 
individual nanoscale particles are enhanced by the layered 
dielectric surface acting as an optical antenna.  The 
interference of reference light reflected from the sensor 
surface with the scattered field produces a distinct signal that 
reveals the size of the particle. On the SP-IRIS platform, we 
demonstrated label-free identification of various viruses in 
multiplexed format in complex samples such as serum or 
whole blood [5] and recently demonstrated in-liquid real-time 
detection of viruses in a microfluidic cartridge [6] without 
requiring upstream sample preparation steps. While individual 
molecular biomarkers remain too small to be imaged directly, 
we have demonstrated the use of small (20 nm diameter) gold 
nanoparticles as secondary tags for the multiplexed detection 
of protein [7] and DNA molecules with attomolar sensitivity. 
Despite the potential for very high sensitivity demonstrated by 
SP-IRIS system, image acquisition and processing remain as a 
significant challenge, and have often required the manual 
intervention of expert operator. We discuss the challenges of 
nanoparticle detection, present the evolution of our SP-IRIS 
platform, and describe a robust image processing method for 
discrimination and accurate counting of nanoparticles.  
II. OPTICAL IMAGING TECHNIQUES FOR NON-FLUORESCENT 
NANO-PARTICLE CHARACTERIZATION 
 
Since its invention in the 17th century, optical microscopy 
has been utilized for visualization of microscale biological 
particles [8]. The resolving power of conventional optical 
microscopy in the visible spectrum allows for direct 
visualization of micron-size particles such as cells and 
bacteria. However, conventional microscopes cannot resolve 
nanoparticles (such as viruses) that are significantly smaller 
than the wavelength of light.  For such particles the contrast of 
the the observed point spread functions (PSF) is proportional 
to light scattering induced by the illumination.  The quasi-
static theory relates the strength of the induced dipole to the 
polarizability of the particle 𝛼 = 4𝜋𝜀!𝑟" 𝜀# − 𝜀$𝜀# + 2𝜀$ 
where r is the particle radius, εp is the particle permittivity, 
and εm is the surrounding medium permittivity. The observed 
intensity at the detector scales with the square of the scattered 
field, resulting in a  r6 signal scaling that rapidly drops below 
the background noise for small nanoparticles. For example, 
when the nanoparticle diameter is reduced from 200nm to 
50nm, the contrast due to scattering is reduced by more than a 
factor of 4,000, making direct detection of nanoparticles very 
challenging. While fluorescence labeling techniques have been 
successfully employed to increase both the sensitivity and the 
resolution of the optical microscope [9, 10], persistent issues 
with photobleaching and nonspecific binding to complex 
media components present significant obstacles. Furthermore, 
variability of fluorescence signal masks the information 
related to the physical size of the biological nanoparticles.  
There are several approaches to overcome the difficulties in 
detection and visualization of non-fluorescent nanoparticles. 
We focus on methods for optical detection of nanoparticles 
captured on a solid surface. Here, we briefly review three of 
the most common methods: (i) optical resonators (such as 
whispering gallery mode devices), (ii) dark-field or evanescent 
excitation imaging, and (iii) interferometric enhancement.  
Resonance is a very powerful technique to enhance weak 
optical interactions. Since the optical scattering from a 
nanoparticle is vanishingly small, a promising way to increase 
the effective interaction is using resonant microcavity 
structures in which the light samples a nanoparticle many 
times before being detected [11], [12]. In this case, light 
circulates in the optical sensors formed by guided-wave 
devices coupled to resonant structures (such as rings, spheres 
or disks) and establishes whispering gallery modes (WGM).  
Nanoparticles captured on the surface of the resonator interact 
with the evanescent tail of the optical wave and perturbs the 
resonance behavior of WGMs in the cavity. Using high-Q 
(quality factor) WGM devices detection of nanoparticles such 
as viruses and single molecules has been demonstrated [12], 
[13]. Despite significant advances and exquisite sensitivity, 
these devices have limited impact on biological detection of 
nanoparticles. One of the critical limitations is low throughput 
capacity. More importantly, these type of sensor devices work 
very well in pure solutions but their sensitivity is significantly 
hampered in complex biological solutions such as serum or 
whole blood.  
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An interesting single nanoparticle detection method 
combines resonant enhancement utilizing a photonic crystal 
sensor surface with imaging.  A one-dimensional photonic 
crystal (PC) surface was utilized to detect surface attachment 
of individual dielectric and metal nanoparticles without 
fluorescence through measurement of localized shifts in the 
resonant wavelength and resonant reflection magnitude [14].   
We review the (ii) dark field and (iii) interferometric 
detection methods in more detail below. These methods have 
the potential of large area imaging and high throughput as well 
as applicability in detection of nanoparticles in complex 
solutions allowing for applications in in vitro diagnostics.    
A. Nanoparticle Detection with Evanescent Illumination 
Dark-field illumination methods enable detection of directly 
scattered light through suppression of background signal.  
Most methods used total internal reflection style illumination 
to generate scattering with an evanescent field interacting with 
nanoparticles captured on the surface.  Because this field 
decays exponentially, only the immediate vicinity of the 
sensor surface is interrogated, and the illuminating field does 
not propagate to the detector.  Compared to standard epi-
illumination microscopy utilizing dark-field objectives, total-
internal reflection and evanescent excitation provide better 
suppression of the background.  
Total-internal reflection (TIR) illumination has been studied 
extensively in the context of TIR fluorescence (TIRF) 
microscopy that images fluorescently labeled biological 
entities close to the interface and it can observe binding of 
single chromophores [15]. Utilizing similar excitation schemes 
and imaging scattered intensity from surface bound 
nanoparticles allows for direct imaging of ~100nm for 
dielectric particles and viruses [16] as well as single ~40nm 
Au nanoparticles [17]. Since scattering intensity scales with 
approximately r6 these techniques are very sensitive to particle 
size.   
An alternative to prism- and objective-based TIR 
illumination is guided-wave illumination that provides a 
highly-controlled evanescent field interacting with 
nanoparticles on the surface [18].  Guided-wave evanescent 
excitation has several advantages over conventional TIR 
illumination including tighter confinement and uniformity of 
the excitation field over large areas. Waveguide-based dark-
field illumination has been utilized for simultaneous 
observation of scattered and fluorescent light from multiple 
surface-associated nanoscopic objects using standard 
microscopes [19].   
A contrasting example for evanescent excitation and 
imaging is Surface Plasmon Resonance Microscopy (SPRM) 
which operates in bright-field. The resonant excitation of the 
surface plasmon waves is sensitive to the local refractive index 
in the vicinity of the metal layer, thus binding of a 
nanoparticle on the metal surface provides a discernible 
signature on the spatial image obtained on the array detector. 
Imaging and detection of sub-100nm silica nanoparticles and 
single H1N1 viruses have been demonstrated by SPRM [20].      
B. Nanoparticle Visualization with Interferometric Imaging 
In contrast to dark-field microscopy relying on suppression 
of the background light, interferometric methods utilize a 
strong reference field (for example background reflection) 
interfering with scattered light to enhance the visibility of 
nanoparticles. In a simplistic manner, the observed intensity 
can be expressed as:  |𝐸% + 𝐸&|' =, |𝐸%|' + |𝐸&|' + 2|𝐸&||𝐸%| cos 𝜃 
where 𝜃 represents the relative phase angle between the 
scattered and reference fields. The first term, |Er|2 is the 
background intensity. The second term, |Es|2 has a very strong 
size dependence (r6) and is negligibly small for particles 
significantly smaller than the illumination wavelength. The 
third cross term has a weaker size dependence (r3) and can be 
much greater than the purely scattered light for small 
nanoparticles. This basic concept applies to heterodyne and 
homodyne interferometric detection techniques. 
Interferometric microscopy method has demonstrated the 
capability of direct visualization of nanoparticles including as 
Figure 1. SP-IRIS detection platform. a) optical setup which 
consist of LED lighting module, imaging objective (50X .8NA) 
and CCD imaging camera. b) Illustration of SP-IRIS sensor 
utilized for protein and nucleic acid detection. c) A sample 
image showing response from individual nanoparticles. 
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small as 5nm Au nanoparticles [21], viruses [22], [23], and 
even individual proteins [24] in laboratory environments and 
pure sample solutions.  
Our optical imaging technique, known as the single-particle 
interferometric reflectance imaging sensor (SP-IRIS) 
visualizes single nanoscale particles by utilizing a common-
path interferometric enhancement [4]. Optical scattering from 
individual nanoscale particles are enhanced by the layered 
dielectric surface acting as an optical antenna.  The 
interference of reference light reflected from the sensor 
surface with the scattered field produces a distinct signal that 
reveals the size of the particle. As we describe below in detail, 
SP-IRIS is capable of detecting dielectric nanoparticles down 
to r=30nm without labels and r=10nm Au nanoparticles used 
as labels conjugated to secondary recognition probes for single 
molecule detection. Below, we describe the evolution of the 
SP-IRIS technology, review the difficulties in accurate sizing 
and discrimination in real-life applications, and present a 
practical and robust image acquisition and processing method.    
III. SINGLE-PARTICLE INTERFEROMETRIC REFLECTANCE 
IMAGING SENSOR (SP-IRIS) 
The Interferometric Reflectance Imaging Sensor (IRIS) is a 
low-cost, compact and simple to use biosensing platform 
developed at Boston University. IRIS has demonstrated high-
throughput detection and quantification of protein-protein 
binding, DNA-protein binding and DNA-DNA hybridization 
in real-time with high sensitivity and reproducibility [4], [25]. 
Recent significant advancements in IRIS technology have 
allowed us to identify individual captured nanoparticles 
through correlation of the observed interference patterns 
intensity with analyte size and shape. This new modality of 
IRIS is termed single-particle IRIS (SP-IRIS). SP-IRIS, as 
illustrated in Fig.1, shines light from an LED source on 
nanoparticles bound to the sensor surface, which consists of a 
silicon dioxide layer on top of a silicon substrate (Fig. 1b). 
Interference of light reflected from the sensor surface is 
modified by the presence of particles producing a distinct 
signal that is captured by a conventional CCD camera. This 
appears as a dot on the image (Fig. 1c), the peak intensity of 
with is correlated to the size of the particle using a forward 
model. Size discrimination reduces the noise from non-
specifically bound particles.  In an SP-IRIS image, as many as 
a million distinct nanoparticles can be simultaneously 
detected. SP-IRIS relies on efficient collection of scattered 
light from nanoparticles and thus requires high magnification 
(50X) and high numerical aperture (0.8), which limits the field 
of view to less than 0.3 mm x 0.3 mm using conventional 
CCD cameras. For DNA arrays with a 100 µm pitch, as many 
as about 10 spots can be imaged at once. To interrogate larger 
arrays, consecutive images are taken to cover the entire IRIS 
sensor using an automated scanning stage.  SP-IRIS can 
operate in either a labeled or label-free modality, as some 
analytes (viruses) can be directly visualized (Figure 1b). 
For smaller analytes (such as individual nucleic acid or 
protein biomarkers), single molecule sensitivity is achieved by 
secondary functionalization of targets captured on the surface 
with a small gold or other metallic nanoparticle.  Labeling 
secondary probes with a particle commonly referred to as 
“mass-tagging” is a prevalent method to enhance sensitivity.  
Mass-tagging approaches employed with conventional 
microscopy require at particles on a size scale of hundreds of 
microns, resulting in limitations due to diffusion and steric 
hindrance of the secondary tag [26], [27]. In contrast, SP- IRIS 
can measure the shape and size of individual nanoparticles as 
small as 20 nm, which is only about twice the hydrodynamic 
diameter of an antibody, allowing this information to serve as 
an identifier of the biomolecule attached to the nanoparticle. 
We term this identifying feature as a “nano-barcode”. Nano-
barcode based detection also improves assay specificity, 
because the nano-barcode has to match the probe it is binding 
over to be considered a positive binding event.  
 
A. Advancement of SP-IRIS technology 
In reviewing the evolution of the technology, we illustrate 
various difficulties in building a robust system for accurate 
sizing and discrimination of nanoparticles. SP-IRIS was first 
introduced in 2010 for high-throughput detection and sizing of 
individual low-index nanoparticles and viruses for pathogen 
identification [5].  Size discrimination of nanoparticles with 
diameters of 70, 100, 150, and 200 nm using an oxide on 
silicon substrate in a wide-field, reflected-mode microscope 
was demonstrated.  For a particular oxide thickness and 
illumination wavelength, the observed intensity of a 
nanoparticle on the surface has a specific size dependence.  
The images acquired and supporting numerical simulations 
were conducted for a single focal plane coinciding with the 
oxide-silicon interface. The successful demonstration of size 
discrimination was enabled by two factors: (i) the 
measurements were done in dry conditions and (ii) the 
samples were prepared by directly depositing the polystyrene 
and viral nanoparticles on the surface rather than a 
biologically relevant capture using immobilized probes. Even 
though these factors allowed for reasonable assumptions 
concerning the axial location of nanoparticles with respect to 
the surface, the authors noted that the varying axial position of 
nanosphere centroids with increasing radius resulted in a 
single-wavelength sizing curve that became double-valued for 
larger particles.  The difficulty of focusing on a layered 
reflecting surface was noted and future corrections were 
suggested utilizing axial scans and fitting the oscillation in 
phase to the forward model at peak response illustrated by a 
numerical study [28] and shown in Fig.2.  
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As the SP-IRIS technology evolved, it was applied to direct 
label-free capture and characterization of viruses from 
complex media such as blood or serum. Affinity-based 
capture, size discrimination, and a “digital” detection scheme 
to count single viruses, yielded a multiplexed and sensitive 
virus sensing assay [5]. These experiments were conducted on 
dry samples after viruses were captured on SP-IRIS chips 
from serum or whole blood contaminated with high levels of 
bacteria. Size discrimination proved very valuable to reduce 
the background noise since the antibody surfaces have 
inherent roughness, and non-specific binding of biological 
particles in complex solutions can be significant. By 
combining the advantages of SP-IRIS, with microfluidics, led 
to real-time digital detection of individual viruses as they bind 
to an antibody microarray [6].   In liquid, the index contrast of 
the particle to the surrounding medium is reduced, resulting in 
a 3-fold reduction compared to dry measurements. 
Furthermore, the captured viral particles may have an axial 
position distribution, especially when elevated using 
immobilized probes with flexible tethers for improved capture 
efficiency [29].   
B. Rigorous modeling of the interferometric signal 
 In SP-IRIS, we employ a Köhler illumination scheme with a 
low-coherence light source that is typically a light emitting 
diode. In this configuration, the light source is in a Fourier 
plane with regards to the sample plane, rendering a final image 
that does not contain the image of the light source. 
Furthermore, each point in the light source produces a plane 
wave incident on the sample at a particular angle defined by 
its position in the transverse plane. It is imperative to note that 
the plane waves do not interfere with one another as there is 
no fixed phase relationships among them owing to the spatial 
incoherence of the light source. Instead, each plane wave 
component of the incident light interacts with the sample 
separately, resulting in a scattered electric field and specularly 
reflected reference field, which interfere among them in the 
detector plane.  The resulting intensity recording is added to 
the final image incoherently, where the final image is the sum 
of all the intensity recordings corresponding to the plane 
waves within the NA of the optical system. The scattered 
electric field is a result of incident light perturbations from the 
nanoparticle, which can be considered as a dipole scatterer, 
when its size is much smaller than the wavelength of the 
incident light. Furthermore, in the case of a common-path 
interferometer, the layered sensor surface can be optimized to 
enhance the scattering in the collection direction, increasing 
the overall interferometric signal.  
Figure 2. The simulated image of particles where the colorbar 
indicates the local contrast (top) and peak contrast values for 
nanoparticles with r=35nm (solid), r=50nm (dotted) and 
r=75nm (dashed) versus the defocus distance (bottom).  
Adapted from [28]. 
 
Figure 3. Spherical gold nanoparticles (r = 30 nm) at (a)  h = 
0 nm (GNP1) and h = 40 nm (GNP2), and (b) their 
interferometric responses (GNP1 shown in red, and GNP2 
shown in blue).  Adapted from [30]. 
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The theoretical foundations of SP-IRIS with an emphasis on 
its key parameters that influence the signal have been studied 
by our group in [30], and a physical model has been realized 
based on this study. In this model, we implement an idealized 
Köhler illumination scheme in which a series of incoherent 
plane waves cover the angular spectrum range defined by the 
NA of the optical system, and are treated separately, i.e., the 
overall signal is the sum of the intensities, instead of the fields. 
We use the angular spectrum representation (ASR) approach, 
as detailed in [31], to map the input electrical field 
components to the corresponding total driving fields at the 
sample plane. Each component of the total driving field 
interacts with the nanoparticle separately, resulting in 
scattered fields modeled using the Green’s function 
formulations for a dipole near a layered substrate geometry as 
detailed in [30]. Following the ASR treatment, the resulting 
scattered field components due to each driving field along 
with the specularly reflected input field component are 
mapped onto the detector plane, where they interfere. The 
calculated intensities for all the driving field components are 
summed to get the overall interferometric signal. Notice that 
the scattered field components depend upon the size and type 
of the particle, as well as the surrounding medium, the 
wavelength of the light, and the layered substrate. 
The rigorous theoretical study in [30] illustrates how 
variation in the axial offset of nanoparticles from the substrate 
surface can dramatically affect appearance and defocus 
behavior.  Figure 3 demonstrates how a change in offset 
smaller than the nanoparticle itself can result in a complete 
inversion of observed signature - while a 60 nm spherical gold 
nanoparticle resting on the surface exhibits a strong negative 
contrast, a 40nm increase in axial elevation alters its response 
to a strong positive peak observed in a different defocus plane.  
Figure 4 shows how even with a consistent plane of surface 
contact, spherical nanoparticles of varying diameter will 
produce variable behavior as a result of the varying position of 
the centers of mass.  The use of surface-immobilized 
biomolecules for analyte capture adds additional variability to 
the thickness of the underlying dielectric layer (simulated in 
Figure 5), a phenomenon that is exacerbated by biofilm 
swelling during in-solution measurements.  The unavoidable 
prevalence of variability in nanoparticle defocus poses a 
significant technical challenge to the adaptation of 
interferometric imaging techniques for clinical applications, 
and will necessitate the development of novel methods for 
data acquisition and image analysis. 
 
IV. ROBUST NANOPARTICLE IDENTIFICATION AND 
DISCRIMINATION 
Although interferometric imaging methods have been well 
established as a tool for nanoparticle characterization, the 
translation of these techniques to a diagnostic context will 
Figure 4 - A) Contrast of center pixel intensity for three sizes of 
polystyrene nanospheres bound to a 30nm oxide on silicon 
substrate.  Significant changes in appearance and defocus 
behavior are observed due to variation in z-axis position of the 
radiating dipole with respect to the reference field generated by 
the reflective surface.  B-D) Line profiles of the observed 
appearance for the three nanospheres simulated for three focal 
plane offsets (-.5, 0, and +.5 µm) with respect to the oxide 
surface.  Simulations were generated for an .9NA in-water 
imaging system.  Circles in plots B-D represent pixel sampling 
locations for a 2 µm pixel pitch with 40x magnification.  
A 
B C D 
Figure 5 - A) Shift in Contrast of center pixel intensity for two 
sizes of polystyrene spheres (100nm and 150nm) due to a change 
in oxide thickness from 30nm to 40 nm. B-C) Line profiles of the 
observed appearance for the three nanospheres simulated for 
two focal plane offsets (-.5 and +.5 µm) with respect to the oxide 
surface.  Simulations were generated for an .9NA in-water 
imaging system.  Circles in plots B and C represent pixel 
sampling locations for a 2 µm pixel pitch with 40x 
magnification.  
A 
B C 
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induce a significant paradigm shift in the validity of many 
assumptions upon which preliminary studies were based.  
Clinical contexts require that these techniques function as a 
concentration measurement instead of as a characterization 
tool.  From this perspective, accurate characterization of 
nanoparticle properties is only relevant to the extent that it 
enables accurate discrimination of chemically specific binding 
events from spurious signals resulting from nonspecifically 
bound scattering objects and morphological variation in 
immobilized capture probes.  While the spatial multiplexing of 
conditions through micro-arrayed capture probes on solid-
phase substrates enables higher level of assay parallelism than 
is achievable in solution-based assays, variations in spot 
morphology and immobilization density increase both the 
prevalence of nonspecific background signal and the expected 
variation in the axial height of captured nanoparticles with 
respect to the reflective surface.  Although early studies 
demonstrated the use of SP-IRIS for concentration 
measurements of unlabeled viral pathogens, these efforts were 
heavily dependent well optimized probe morphology, manual 
focal control by a skilled operator, and the ability to assume of 
homogenous nanoparticle properties and axial locations [5], 
[6]. 
Because diagnostically relevant nanoparticles are typically 
much smaller than the wavelength of illuminating light, their 
appearance in wide-field images takes the form of radially 
symmetric regions of alternating positive and negative 
contrast.  The rotationally invariant nature of these 
interference patterns makes it possible to identify the centroids 
of these nanoparticle signatures through simple template 
matching algorithms, provided that the analysis algorithm is 
capable of creating a sufficiently accurate simulated template.  
While this process is widely employed to identify point spread 
functions (PSFs) in conventional fluorescence and bright-field 
microscopy images, where PSF appearance is determined 
solely by optical system parameters, the interferometric nature 
of SP-IRIS measurements produces a much larger parameter 
space of possible template appearances.  Even without the 
variability induced by changes in nanoparticle axial location, 
small errors in substrate alignment (on the order of tenths of a 
degree) can result in heterogeneous defocus behaviors for 
identical nanoparticles in different regions of a single field of 
view.  Figure 7 shows a raw image of 100 nm PS nanospheres 
physisorbed onto a 30 nm oxide substrate in water, displaying 
varying positive or negative contrast appearances for different 
regions.  External measurements performed during system 
calibration indicate a misalignment of no more than one 
quarter of a degree, demonstrating the extremely high 
calibration diligence required for accurate nanoparticle 
characterization over a wide field of view using only single-
plane images.  While preliminary studies were able to 
minimize this variability through careful alignment and 
sample quality control, such strict tolerance requirements will 
not be compatible with widespread use of these techniques by 
unskilled operators. 
In an effort to overcome the obstacles posed by variable 
defocus behavior, recent advancements in automated imaging 
and analysis have shown that the change in intensity 
experienced by a nanoparticle signature over the extent of a 
given range of focal planes, or differential contrast, is 
considerably more predictable than its specific appearance in 
any single image, as shown through simulations in Figure 6.  
Figure 6.  Compressed images for three diameters of 
Polystyrene nanospheres (70, 100, and 150 nm) imaged in water 
are generated by collecting the maximum and minimum 
normalized intensities present over a sequence of sequentially 
defocused images on a per-pixel basis.  Solid lines denote 
compressed signatures from nanospheres on 30nm oxide, and 
dashed lines denote signatures from a 40nm oxide.  The 
underlying Z-stacks are composed of 61 images simulated for a 
.9 NA imaging system in water at 200 nm increments over a 6 
µm range centered on the oxide surface.   
A) Largest positive contrast values per pixel.  B) Largest 
negative contrast per pixel.  C) Total differential contrast 
generated from the subtraction of plots in B from A.  
Differential contrast measurements demonstrate strong 
agreement between conditions despite significant variation in 
single – plane appearance and defocus behavior.   
B 
C 
A 
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The nanoparticle response generated by the calculation of 
differential contrast collapses into a consistent profile 
regardless of amplitude or defocus behavior, enabling the 
straightforward identification of nanoparticle locations within 
an image using simple template matching methods.  
Furthermore, the amplitude of the differential contrast 
signature provides a consistent metric for size-based 
discrimination. Using this concept, we have developed an 
algorithm for the robust measurement of the concentration of 
surface-bound nanoparticle populations regardless of 
heterogeneity in size and axial offset.
Figure 7.  A) Nominally focused image of 100nm Polystyrene nanospheres physisorbed on a 30nm thick oxide substrate.   Images 
were acquired with a 40x, .9NA objective a water-filled microfluidic flow cell.  Colored Boxes identify the locations of representative 
nanoparticles taken from different regions of the field of view.  B) Differential contrast image generated from the total peak to peak 
change in intensity over a 6 µm Z-stack sampled at 200nm increments.  C) Crops of the observed appearance of representative 
nanoparticles from the colored regions in A.  D) Differential contrast crops of identical regions from B.  E) Centerline profiles of the 
regions shown in C, displaying varying appearance due to slight sample misalignment.  F) Centerline profiles of regions in D, 
demonstrating consistent signal via differential contrast. 
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 Initially, a nominal focal plane is identified via an autofocus 
algorithm utilizing a finite impulse response filter optimized 
for the critical spatial frequency of the optical system [32], 
after which a z-stack is acquired at 200nm increments over a 6 
micron range centered at the starting point.  Each slice of the 
z-stack is normalized into units of local contrast by dividing 
the raw image by a low-pass filtered background image.  This 
3D data structure is used to calculate the maximum peak to 
peak intensity experienced by each pixel over the total range 
of defocus positions within the z-stack, resulting in a two 
dimensional image differential contrast in which signatures 
from a heterogeneous population of nanoparticles are 
collapsed into a single consistent profile.  A simulated 
template is generated by using the above method to compress 
simulated images generated by the SP-IRIS physical model.  
Cross-correlating this template with the differential contrast 
image results in a 2D correlogram, in which each pixel 
represents the probability that said location is the center point 
of a diffraction limited scattering object.  The (x,y) locations 
of probable nanoparticle locations is then generated through 
simple morphological peak detection after thresholding this 
2D correlogram by a high probability integer (typically 90%).  
These (x,y) locations are then used to extract contrast traces of 
nanoparticle centroids from the original z-stack, from which 
nanoparticles sizes are discriminated via their total change in 
intensities.  Finally, the concentration of bound nanoparticles 
is determined by taking the ratio of the total number of 
confirmed nanoparticles with desired characteristics to the 
interrogated area. 
Figure 8.  Block diagram of algorithm for nanoparticle detection and counting using z-stacks of incrementally defocused images. 
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V. CONCLUSIONS 
In this paper, we have reviewed an array of optical imaging 
techniques capable of direct detection of nanoparticle 
biomarkers without fluorescent labels. We consider wide-field 
imaging as the most promising technique due to its simplicity 
and high throughput. We have focused on interferometric 
imaging and discussed the evolution of Single-Particle 
Interferometric Reflectance Imaging Sensor (SP-IRIS) from a 
laboratory instrument requiring manual operation by a skilled 
operator to an automated tool for diagnostic applications. 
 
While the performance capabilities of interferometric 
imaging techniques have been widely demonstrated, their 
stringent calibration and characterization requirements have 
often been identified as significant obstacles to their 
translation to clinical environment. As we demonstrated in this 
paper, it is crucial to establish a rigorous model for the optical 
signatures of nanoparticles and develop a robust image 
acquisition and analysis technique. We have identified 
challenges associated with defocus, alignment, and 
nanoparticle orientation, and introduced a concept for robust 
nanoparticle detection and discrimination despite the presence 
of these phenomena. 
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